Thromb Haemost 2020; 120(04): 620-626
DOI: 10.1055/s-0040-1708482
Coagulation and Fibrinolysis
Georg Thieme Verlag KG Stuttgart · New York

Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

Pablo Javier Marchena*
1   Department of Internal Medicine and Emergency, Parc Sanitari Sant Joan de Déu-Hospital General, Barcelona, Spain
,
Inna Tzoran*
2   Department of Haematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
,
Benjamin Brenner
2   Department of Haematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
,
Mar Martín
3   Department of Internal Medicine, Hospital Universitario Infanta Sofía, Madrid, Spain
,
Radovan Malý
4   Department of Cardiovascular Medicine I, Charles University in Prague, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Czech Republic
,
Alessandra Bura-Riviere
5   Department of Vascular Medicine, Hôpital de Rangueil, Toulouse, France
,
Reina Valle
6   Department of Internal Medicine, Hospital Sierrallana, Santander, Spain
,
Luis Hernández-Blasco
7   Department of Pneumonology, Hospital General Universitario de Alicante, ISABIAL, Alicante, Spain
,
Juan Bosco López-Sáez
8   Department of Internal Medicine, Hospital Universitario de Puerto Real, Cádiz, Spain
,
Manuel Monreal
9   Department of Internal Medicine, Hospital Germans Trias i Pujol, Universidad Autónoma de Barcelona, Badalona, Barcelona, Spain
,
RIETE Investigators› Author Affiliations

Funding The RIETE registry is sponsored by Sanofi with an unrestricted educational grant.
Further Information

Publication History

05 November 2019

01 February 2020

Publication Date:
14 April 2020 (online)

Preview

Abstract

Background The influence (if any) of the use of psychotropic drugs on outcome in patients receiving anticoagulant therapy for venous thromboembolism (VTE) has not been consistently evaluated.

Methods We used data from the RIETE (Registro Informatizado Enfermedad TromboEmbólica) database to compare the risk for VTE recurrences, major bleeding, or death during the course of anticoagulant therapy, according to the use of psychotropics at baseline.

Results Among 49,007 patients with VTE enrolled from February 2009 to September 2019, total 5,230 (11%) were using psychotropics at baseline: antidepressants 3,273 (6.7%), antipsychotics 1,588 (3.2%), and anticholinesterases 369 (0.7%). During the course of anticoagulation, 1,259 patients developed VTE recurrences, 1,231 bled, and 3,988 died (fatal pulmonary embolism 269 and fatal bleeding 187). On multivariable analysis, patients using psychotropics at baseline had a similar risk for VTE recurrences (adjusted hazard ratio [HR]: 0.81; 95% confidence interval [CI]: 0.58–1.12), a nonsignificantly higher risk for major bleeding (adjusted HR: 1.15; 95% CI: 0.97–1.35), and a higher risk for intracranial bleeding (adjusted HR: 1.83; 95% CI: 1.32–2.53) or death (adjusted HR: 1.44; 95% CI: 1.32–1.57) compared with those not using psychotropics. When separately analyzed, the highest risk for intracranial bleeding was found in patients using antidepressants (adjusted HR: 1.60; 95% CI: 1.08–2.37) or antipsychotics (adjusted HR: 2.02; 95% CI: 1.17–3.49) but not in those on anticholinesterases (adjusted HR: 1.69; 95% CI: 0.62–4.60).

Conclusion During the course anticoagulation for VTE, patients using psychotropics at baseline were at increased risk for intracranial bleeding.

Note

Coordinator of the RIETE Registry: M.M.


RIETE steering committee members: P.P., B.B., and D.F.B.


RIETE national coordinators: R.B. (Spain), P.D.M. (Italy), L.B. (France), S.S. (Germany), I.T. (Israel), A.R. (Portugal), M.B. (R. Macedonia), H.B. (Switzerland), R.M. (Czech Republic), P.V. (Belgium), J.A.C. (USA), and H.Y.B. (Vietnam).


RIETE Registry Coordinating Center: S & H Medical Science Service.


* Pablo Javier Marchena and Inna Tzoran equally contributed to the study.


** A full list of RIETE investigators is given in Supplementary Appendix A (available in the online version).


Supplementary Material